7th Central European Congress of Life Sciences

23-25 September 2019

PROGRAMME BOOK

Editor:Congress Organizing OfficeTargi w Krakowie Ltd.9 Galicyjska St.31-586 Krakow, Polandwww.targi.krakow.plwww.expokrakow.com

Project Manager: Justyna BaziaGraphics, DTP: Barbara Lewanowicz

CONTENTS

Welcome Message................................................................... 4

Organizing & Scientific Committees ........................................ 5

Patronages & Partners ............................................................. 6

General Information.................................................................. 7

Scientific Programme ............................................................. 10

Index of Posters Authors ........................................................ 17

List of Posters Presentations .................................................. 19

Sponsors and Exhibitors ........................................................ 33

List of Exhibitors ..................................................................... 46

4

Dear Participants of the 7th Central European Congress of Life Sciences Eurobiotech.

It is an honour and pleasure to welcome you to the Eurobiotech 2019. The science and technology are a foundation of the future of our knowledge based on bioeconomy. After a great success of the previous six editions of the Congress, we are continuing the mission of bringing the most recent scientific findings and technical advances to the community of biotechnology scientists and industry. Our Congress is becoming more and more significant every year. It is our aim to make sure that this edition of the Congress will meet the most demanding requirements.In 2019 we look forward to an exciting Congress with the great scientific debates and fantastic interactions with the political and business leaders, top researchers and investors. We present an inspiring program including a group of distinguished speakers -the best specialists in the field of biotechnology. We sincerely thank all of you for submit-ting the most recent achievements. Let me warmly welcome you in the beautiful city of Krakow. On behalf of the Organizing Committee we wish you all a successful meeting, a great science and a scientifically stimulating experience. And don’t forget that we are looking forward to spending this enjoyable time with you in Krakow!

Tomasz TwardowskiChairman of the Eurobiotech Scientific Committee 2019

WELCOME TO EUROBIOTECH 2019!

5

Scientific Committee:

CHAIRMAN:Tomasz TwardowskiPresident of the Biotechnology Committee, Polish Academy of Sciences

VICE-CHAIRMAN:Józef DulakJagiellonian University in Krakow

VICE-CHAIRWOMAN: Aleksandra MałyskaEuropean Technology Platform ‘Plants for Europe’

Jan BarciszewskiInstitute of Bioorganic Chemitry, PolishAcademy of Sciences, Poznan

Hans BluyssenAdam Mickiewicz University in Poznan

Jan ChłopekAGH University of Science and Technology, Krakow

Maria Anna Ciemerych-LitwinienkoUniveristy of Warsaw

Marta Dziedzicka–WasylewskaJagiellonian University in Krakow

Andrzej KononowiczUniversity of Lodz

Piotr LaidlerJagiellonian University in Krakow

Krzysztof PyrćJagiellonian University in Krakow

Kazimierz StrzałkaJagiellonian University in Krakow

Grzegorz WęgrzynUniversity of Gdansk

Local Organizing Committee:

Ewa WochTargi w Krakowie Ltd., Chair

Tomasz TwardowskiPresident of the Biotechnology Committee PAS, Co-chair

Justyna BaziaTargi w Krakowie Ltd.

Agnieszka ZiemiańskaTargi w Krakowie Ltd.

COMMITTEES

6

PATRONAGES & PARTNERS

Partners:

Media Patronages:

Patronage:

7

GENERAL INFORMATION

BADGES AND REGISTRATIONThe Registration Desk is located at the entrance lobby of the EXPO Krakow

OPENING HOURSMonday, September 23, 2019 8:00–18:30Tuesday, September 24, 2019 8:30–18:30Wednesday, September 25, 2019 8:30–15:30On-site registration is possible during Registration Desk opening hours.

For security reasons, badges must be worn at all times inside the congress venue and at all events related to the Eurobiotech Congress (this includes lunches and evening social programme for delegates and accompanying persons).

VENUE INFORMATIONThe Congress takes place at the International Exhibition and Convention Centre EXPO Krakow,9 Galicyjska St., 31-586 Kraków, Poland.Conference rooms are: Wiedeń and Budapeszt.

SPEAKER PREVIEW ROOMA speaker preview room is located on the ground floor, Meeting Room SO6.

LANGUAGEThe official language of the event is English

EMERGENCY SERVICESThe European Emergency Number is 112.For Police, dial 997.For Fire, dial 998.For Ambulance, dial 999.Using mobile phones: remember to dial the local code before the number, for example:12 – 997 to call the police in Krakow.

TAXISThe best way to order a taxi is by telephone.Calling ahead will get you a better fare.Please find taxi numbers below:Taxi BARBAKAN: + 48 609 400 400iCAR: +48 12 653 5555, +48 12 888 0000Mega Taxi: +48 12 400 00 00, +48 12 196 25

10

Monday, 23.09.2019BUDAPESZT LECTURE ROOM

10:00-11:30 Satellite Session 1: To publish or not to publish?Dr Agata Tyczewska & Prof. Jeff Cole & Dr Lynn Sherrer11:30-12:30 Satellite Session 2: ”AgroBioTop”, Biotechnology Committee PAN & Bayer Chair: Jerzy Próchnicki, Bayer & Prof. Maciej Żylicz, The Foundation for Polish Science & Prof. Tomasz Twardowski, Biotechnology Committee PASDr Beata Hasiów-Jaroszewska Innovative tools for detection of pathogenic viruses – an important element of plant protection in modern agricultureDr Piotr Oleśkowicz-Popiel Resource recovery from waste – chain elongation as a method for valorisation of organic side streams

WIEDEŃ LECTURE ROOM

12:45-14:20 Opening Ceremony12:45-12:50 Welcome & OpeningChair: Prof. Tomasz Twardowski, Chairman of Biotechnology Committee PAS, Institute of Bioorganic Chemistry PAS, Poznań

12:50-13:35 Opening Lecture 1 Prof. Ikuko Hara-NishimuraChair: Prof. Kazimierz StrzałkaAdjustment of plant posture by actin-myosin XI cytoskeleton-mediated organ straightening

13:35 – 14:20 Opening Lecture 2 Dr Christopher RidoutChair: Prof. Andrzej KononowiczNovel approaches to durable disease resistance in crop improvement

14:20-14:45 Comprehensive genomic profiling in oncology Dr Aleksander Sowa, Roche Polska

14:45-15:15 Coffee break (location: EXPO Kraków lobby)WIEDEŃ LECTURE ROOM BUDAPESZT LECTURE ROOM

Session 1 Drug discovery and novel therapeutic strategiesChair: Prof. Hans Bluyssen

Session 2 Plant breeding innovationChair: Dr Aleksandra Małyska

15:15–15:45 Keynote Lecture 1.1 Prof. Jan HoeijmakersAnti-aging therapies in neurodegenerative diseases

15:15–15:45 Keynote Lecture 2 Prof. Stefan JanssonGenome editing in plants using CRISPR/Cas9 and the European GMO legislation

SCIENTIFIC PROGRAMME

11

15:45-16:15 Keynote Lecture 1.2 Prof. Robert BristowClash of the Titans: Targeting Tumour Genomics or the Tumour Micro-environment?

15:45-16:00 Veronika Lancíková2.1 When size does matter: mutation breeding brought more nutritionally valuable amaranth grains

16:00-16:15 Tomasz Zimny 2.2 New plant breeding techniques and GMO legislation – approaches, solutions and policy making

16:15-16:30 Hans Bluyssen1.1 STATs in Vascular Inflammation: Transcriptional regulators and Therapeutic targets

16:15-16:30 Barbara Pawełek2.3 Analysis of sex proportion disturbances factors in selected Rumex species

16:30-16:45 Tomasz Rzymski1.2 Development of next generation anticancer therapies based on synthetic lethality concept

16:30-16:45 Weronika Babińska 2.4 Antibacterial properties of post-plasma solutions against Pectobacterium and Dickeya spp

WIEDEŃ LECTURE ROOM

16:45-17:00 Joanna Uchańska, Partner at Chałas and Partners Law Firm and Bioethics and Medical Law Department, Law and Administration Faculty, the Jagiellonian UniversityATMP: Legal challenges and its frontiers in stem cell pharmacogenetics and pharmacogenomics

Session 3Materials for biomedical applicationsChair: Prof. Jan Chłopek & Prof. Joachim Kohn17:00–17:30 Keynote Lecture 3 Prof. Elżbieta PamułaSmart, lipid-based drug delivery systems to the lungs

17.30-17:45 Esther Vázquez3.1 Bacterial Amyloids for the Remote Release of Tumor-Targeted Protein Drugs

17:45-18:00 Patrycja Domalik-Pyzik3.2 Biopolymers-based composites: synthesis, characterization and application in tissue engineering

18:00-18.15 Agnieszka Leszczyńska3.3 Thermal stability of cellulose nanocrystals – the influence of manufacturing conditions and surface modification

18.15-18.30 Hatice Ercan3.4 Assessment of Mussel-Inspired Carrageenan Hydrogels

18:35 Welcome Cocktail (EXPO Kraków lobby)

12

Tuesday, 24.09.2019

WIEDEŃ LECTURE ROOM BUDAPESZT LECTURE ROOM

Session 4 Small and long nucleic acids therapeuticsChair: Prof. Jan Barciszewski & Prof. Piotr Laidler & Prof. Marta Dziedzicka - Wasylewska

Session 5Plant’s clinicChair: Dr Beata Hasiów-Jaroszewska & Dr Inge Hanssen

9:00–9:30 Keynote Lecture 4 Dr Petar Glažar Expression and functions of neuronal circular RNAs

9:00–9:30 Keynote Lecture 5.1 Dr Beata Hasiów-JaroszewskaDevelopment of new diagnostic methods for rapid and efficient detection of pathogens

9:30-10:00 Katarzyna Rolle4.1 miR-218 impacts the extracellular matrix (ECM) rearrangements and bio-mechanical properties of the GBM cells

9:30-9:45 Krzysztof Treder5.1 Reverse-transcription loop-mediated isothermal amplification as an innovative tool for the detection of RNA-pathogens infecting potato plants

10:00-10:15 Bogna Kuczyńska4.2 Circular RNAs as a potential prognostic marker and therapeutic target in glioblastoma multiforme

9:45-10:15 Keynote Lecture 5.2Dr Inge HanssenVaccination to control Pepino mosaic virus in tomato: from basic research to a registered biocontrol product

10:15-10:30 Marcin Równicki4.3 Intracellular bombs triggered by antisense Peptide Nucleic Acids. Artificial activation of E. coli toxin-antitoxin systems as an antibacterial strategy

10:15-10:30 Robert Czajkowski5.2 Innovative mixture of beneficial microorganisms, developed to protect potato tubers against soft rot in storage

10:30–12:00 Poster session & Coffe break (location: EXPO Kraków lobby)WIEDEŃ LECTURE ROOM

12:00-12:45 Plenary Lecture 1 Dr Salma BalazadehChair: Prof. Kazimierz StrzałkaUnraveling stress response networks in plants: from gene regulatory grids to proteome control circuits

12:45-13:30 Satellite Session 3: Commercialization of research results in life sciences – good practices from the Polish universitiesProf. Paweł Zajdel, Dr Radosław Rudź First commercialization of drug development project from Jagiellonian UniversityDr Joanna Kowalska, Renata Olejnik Therapeutic mRNA – from ideato commercialization

13:30–14:30 Lunch break (location: EXPO Kraków lobby)

13

WIEDEŃ LECTURE ROOM

14:30–15:15 Plenary Lecture 2 Prof. Jan HoeijmakersChair: Prof. Hans BluyssenThe role of DNA damage repair and transcription stress in aging and the impact of nutrition

WIEDEŃ LECTURE ROOM BUDAPESZT LECTURE ROOM

Session 6Organoids and organs on chipsChair: Józef Dulak

Session 7Environmental and industrial biotechnology in circular economyChair: Dr Piotr Oleśkowicz-Popiel

15:15–15:45 Keynote Lecture 6 Prof. Robert PassierAdvanced human stem cell-based models of cardiac disease

15:15-15:45 Keynote Lecture 7 Prof. Jens Ejbye SchmidtBiorefineries for fuels and chemicals

15:45-16:00 6.1 Dr Charles Amirmansour; BioTek Instruments, Inc. Cytation 5 Technology: An Advanced Tool for Smarter Target-Based, Phenotypic Research & Screening

15:45-16:00 Filippo Brienza7.1 Investigating the influence of process conditions on the fractionation of lignocel-lulosic biomass from agricultural residues with a focus on lignin valorization

16:00-16:10 Neli Kachamakova-Trojanowska6.2 Modeling of endothelial (dys)function in maturity onset diabetes of the young using human induced pluripotent stem cells

16:00-16:15 Carmen Hsieh7.2 Applying circular bioeconomy principles to a Green Biorefinery at pilot/demo plant scale

16:10-16:20 Teodora Ranđelović6.3 Glioblastoma on chip – the role of microenvironment in tumour progression and drug resistance development

16:15-16:30 Tanmay Chaturvedi7.3 Halophyte based aquaponic system for a biorefinery

16:20-16:30 Alexander Ainscough6.4 Investigating Pulmonary Arterial Hypertension using the pulmonary artery-on-a-chip

16:30-16:45 Mateusz Łężyk7.4 Syngas-fermenting microbial consortia for bioethanol and biomethane production – characterization and design of enrichment strategies16:30-16:40 Sandra González Lana

6.5 Surface functionalization to control biomimetic mechanical environment in COP based microfluidic devices

14

Session 8Microbial biotechnology and nanotechnologyChair: Prof. Grzegorz Węgrzyn

Session 9Recent advances in RNA interference technology and the use of nucleic acid-based toolsChair: Prof. Anna Kurzyńska-Kokorniak

16:45–17:15 Keynote Lecture 8 Prof. Antonio VillaverdeEngineering protein drugs for precision nanomedicines of cancer

16:45–17:15 Keynote Lecture 9 Prof. Zofia Szweykowska-KulińskamicroRNA 444.1: a key regulator of tillering in barley plant upon heat stres

17:15-17:30 Bart Krist8.1 Magnetic core nanoparticles coupled with STATTIC as a targeted approach to multi-STAT inhibition in CVD

17:15-17:45 Wojciech Strzałka9.1 Application of an anti-PCNA aptamer for inhibition of activity of replicative human DNA polymerase delta and epsilon

17:30-17:45 Peter Gajdoš8.2 Metabolic engineering of Yarrowia lipolytica for production of attractive lipophilic compounds

17:45-18:00 Adrian Augustyniak8.3 Effects of graphene oxide on secondary metabolism of streptomycetes and pseudomonads

17:45-18:15 Natalia Koralewska9.2 Short oligonucleotides as precursor-specific regulators of microRNA maturation

18:00-18:15 Nathania Puspitasari8.4 Recombinant Hydrophobin Enhanced Polyethylene Terephthalate Hydrolysis by PETase

Wednesday, 25.09.2019

WIEDEŃ LECTURE ROOM BUDAPESZT LECTURE ROOM

Session 10Gene and cell therapiesChair: Prof. Józef Dulak & Prof. Anna M. Ciemerych-Litwinienko

Session 11Plants and environmental stressChair: Prof. Kazimierz Strzałka & Dr Kenji Yamada

9:00–9:30 Keynote Lecture 10 Prof. Jeffrey ChamberlainDevelopment of gene therapy for muscular dystrophy using AAV-delivery of micro-dystrophin

9:00–9:30 Keynote Lecture 11 Dr Krzysztof ZienkiewiczTowards Improving Microalgae-Based Biofuel Production

9:30-9:45 10.1 SPONSOR SPEECH Eddy van Collenburg - Droplet Digital PCR Specialist Europe, Bio-Rad Laboratories BVddPCR: A new and reliable tool for absolute quantification in Gene and Cell Therapy applications

9:30-9:45 M. Aydin Akbudak11.1 Boron Resistance Genes in European Alkali Grass (Puccinellia distans L.)

15

9:45-9:55 Ryszard Rzepecki 10.2 New tools for gene therapy for progeria and muscle-related rare disorders

9:45-10:00 Marcin Filipecki11.2 The retrograde signaling of high light stress coordinatively engages ROS- and miRNA-related components

9:55-10:05 Izabela Kraszewska10.3 Cardiac miRNA-122 level varies between mouse strains and among human individuals and determines therapeutic potential of miRNA-regulated AAV9 vectors

10:05-10:15 Monika Żukowska10.4 NEO1 marks lineage-biased hematopoietic stem cells

10:00-10:15 Ankush Prasad11.3 Imaging of reactive oxygen species as a response to environmental stress: an in vivo study

10:15-10:25 Jacek Stępniewski10.5 Comparison of therapeutic effect of genetically modified adipose derived stromal cells and induced pluripotent stem cells-derived cardiomyocytes in small and large model of myocardial infarction

10:15-10:30 Shino Goto-Yamada 11.4 Microautophagic vesicle formation requires autophagy-related genes under starvation in plants

10:30-12:00 Poster session & Coffe break (location: EXPO Kraków lobby)

Session 12Vaccines and AntiviralsChair: Prof. Krzysztof Pyrć

Session 13AgribiotechnologyChair: Prof. Andrzej K. Kononowicz

12:00–12:30 Keynote Lecture 12 Prof. Benjamin Berkhout CRISPR-Cas towards a cure for HIV

12:00–12:30 Keynote Lecture 13 Kumar GauravMining wild wheat diversity for disease resistance

12:30-12:45 Anna Kula-Pacurar 12.1 Role of nuclear matrix protein MATR3 in HIV latency and reactivation: new implications for therapy

12:30-12:45 Maciej Kosiński13.1 Polish isolate of baculovirus LdMNPV-BNP activate cover infection increasing speed of kill of susceptible forest pest

12:45-13:00 Aleksandra Milewska12.2 HTCC – broad range inhibitor of coronaviral infections

12:45-13:00 Miron Gieniec13.2 A model system for multiplex carrot genome editing with constitutively expressing Cas9 and Cas12a proteins

13:00-13:15 Antonina Naskalska12.3 Membrane protein of HCoV-NL63 is responsible for interaction with the adhesion receptor

13:00-13:15 Magdalena Liszniańska13.3 Rumex tianschanicus x Rumex patientia an energy plant well adapted to moderate climate conditions

16

13:15-13:30 Parvez Singh Slathia12.4 Designing of epitope based vaccine based on common conserved epitopes of Japanese Encephalitis Virus, West Nile Virus and Zika Virus using in silico methods

13.15-13:30 Dejan Prvulović13.4 Allelopathic effects of industrial hemp (Cannabis sativa L.) on antioxidant enzymes activity of soybean seedlings

WIEDEŃ LECTURE ROOM

13:35-16:00 Closing CeremonyChair: Prof. Tomasz Twardowski, Chairman of Biotechnology Committee PAS, Institute of Bioorganic Chemistry PAS, Poznań13:35-14:20 Closing Lecture 1 Prof. Joachim KohnChair: Prof. Jan ChłopekChallenges and opportunities of biomaterials for tissue engineering

14:20-15:05 Closing Lecture 2 Dr Stanisław FlasińskiChair: Prof. Tomasz TwardowskiAdvances in Sustainable Ag Biotechnology to Control Insect Pests with Insecticidal Proteins and RNAi

15:05-15:15 Closing and Good-bye address Prof. Tomasz TwardowskiAnnoucement of the awards of the Best Poster Prize winners (free registrations for the ECB2020 in Maastricht)Annoucement of the next edition of Eurobiotech Congress

15:15-16:00 Lunch (location: EXPO Kraków lobby)

17

Akbudak M. Aydin ........................... P11.1Andrysiak Kalina ............................. P10.1Antonczyk Aleksandra ...................... P1.1Augustynowicz Joanna................... P11.2Baranski Rafal ................................... P8.1Botwina Paweł ................................. P12.1Bronisz-Budzyńska Iwona .............. P10.2Brzuska Gabriela ............................ P12.2Chaloupsky Pavel ............................. P8.2Chmielewska-Kassassir Małgorzata P1.2Chyb Maciej ...................................... P1.3Cybulska Magdalena ........................ P1.4Dąbrowska Agnieszka .................... P12.3Debiec-Andrzejewska Klaudia ......... P8.3Drabczyk Anna ................................. P1.5Dzianisava Volha ............................. P10.3Dzierżyńska Maria............................. P3.1Ekiert Halina .................................... P11.3Ekiert Halina .................................... P11.4Fandiño Estefania ............................. P1.6Felczak Aleksandra........................... P8.4Fiedor Elzbieta .................................. P1.7Filipecki Marcin ............................... P11.5González Lana Sandra ..................... P3.2Gómez-Linton Darío ......................... P1.8Góralczyk-Bińkowska Aleksandra .... P8.5Góralczyk-Bińkowska Aleksandra .... P8.6Grabiec Aleksander M ...................... P1.9Grochowski Radosław .................... P10.4Grzebelus Dariusz .......................... P11.6Grzegorz Kłosowski .......................... P8.7Grzyb Katarzyna ............................. P1.10Hałat-Łaś Małgorzata ....................... P8.8Hambalko Jaroslav ........................... P8.9Hemidouche Sabra ........................ P8.10Jafernik Karolina .............................. P5.1Janicki Tomasz ................................ P8.11Jarocki Piotr .................................... P8.12Jelínková Šárka ............................... P10.5Jeż Mateusz ...................................... P6.1Józefczuk Ewelina .......................... P1.11Kaczmarek Agata ............................. P5.2Kała Katarzyna ................................ P1.12Kania Kinga ..................................... P11.7

Kaszycki Paweł ............................... P13.1Kłosowski Grzegorz ........................ P8.13Koim-Puchowska Beata ................. P8.14Koim-Puchowska Beata ................. P8.15Komoń-Janczara Elwira .................. P8.16Kopacz Aleksandra......................... P1.14Kosowska Karolina ........................... P3.3KowalczykAnna ............................... P11.8Krzykawski Marcin .......................... P1.15Kuczyński Jakub ............................. P11.9Kulus Dariusz .................................. P13.2Kułaga Damian ............................... P1.13Kusienicka Anna ............................. P10.6Kuźniar Agnieszka .......................... P8.17Kwiecień Inga ................................ P11.10Kwiecień Inga ................................ P11.11Kwolek Kornelia ............................ P11.12Laskowska-Kaszub Katarzyna ....... P1.16Laskowska-Kaszub Katarzyna ......... P4.1Lee Wen-Chien ............................... P1.17Litwin Anna ...................................... P13.3Litwinska Zofia .................................. P4.2Loboda Agnieszka .......................... P10.7Lukasiewicz Aneta ........................ P11.13Łuczkowska Karolina ...................... P1.18Majewska Edyta .............................. P8.18Malinowska Magdalena.................... P3.4Manrique-Moreno Marcela ............. P1.19Martyniak Alicja ............................... P10.8Mazurkiewicz Natalia ...................... P1.20Menka Aleksandra .......................... P8.19Menka Aleksandra .......................... P8.20Miastkowska Małgorzata ................ P13.4Michalski Krzysztof .......................... P2.1Mielczarek Mateusz .......................... P5.3Mikulski Dawid ................................ P8.21Mikulski Dawid ................................ P8.22Mironenka Julia ............................... P8.23Miszkiewicz Joanna ........................ P8.24Mucha Olga .................................... P10.9Myszka Kamila ................................ P13.5Natonek-Wiśniewska Małgorzata ... P13.6Natonek-Wiśniewska Małgorzata ... P13.7Nowak Marta ................................... P8.25

INDEX OF POSTERS AUTHORS

18

Nowak Marta ................................... P8.26Nowak Monika ................................ P8.27Olchawa-Pajor Monika ................. P11.14Osmolovskiy Alexander .................. P1.21Owczarek Katarzyna ....................... P12.4Pachota Magdalena ....................... P12.5Parvez Singh Slathia ...................... P8.33Pawłowska Anna ............................... P5.4Pierzynowska Karolina .................... P1.22Plens-Gałąska Martyna .................. P1.23Podbielska Angelika ....................... P13.8Podkalicka Paulina ........................ P10.10Pokrywka Małgorzata ..................... P13.9Popielec Agnieszka ........................ P1.24Prasertsan Poonsuk ........................ P8.28Radko Anna .................................. P13.10Regdos Kinga ................................. P8.29Rogińska Dorota ............................... P3.5Rychlicka Magdalena ..................... P1.25Sikora Elzbieta .................................. P3.6Sikora Elżbieta ................................. P3.7Sobieszczańska Natalia ............... P13.11Sobuś Anna .................................. P10.11Sochalska Maja .............................. P1.26Speranza Jasmine ........................ P11.15

Spórna Klaudia ............................. P13.12Starosta Alicja ................................. P1.27Strąk-Graczyk Ewelina .................. P13.13Strąk-Graczyk Ewelina .................. P13.14Synowiec Aleksandra ..................... P12.6Szczepański Artur ........................... P12.7Szczerba Hubert ............................... P7.1Szychowski Konrad A. .................... P1.28Śliwa-Cebula Marta ...................... P11.16Tomaszewska Agata ....................... P1.29Tyczewska Agata .......................... P11.17Wojciechowska Monika .................. P1.30Woźniak Ewa ................................. P13.15Wójcik Danuta ............................... P13.16Wójcik Danuta ............................... P13.17Wrońska Natalia .............................. P8.30Yang Zhendong .............................. P8.31Zaręba Przemysław ........................ P1.31Zarzyńska-Nowak Aleksandra .......... P5.5Zawadzka Katarzyna ...................... P8.32Zimny Tomasz ............................... P10.12Ziółkowska Sylwia ........................... P1.32Żbik Paweł ..................................... P11.18Żebrowska Joanna .......................... P3.8Żurek Grzegorz ................................. P2.2

19

LIST OF POSTERS PRESENTATIONS

POSTER NUMBER

TITLE, AUTHORS

Session 1 Drug discovery and novel therapeutic strategies

P1.1 Identification of pan-IRF inhibitory compounds as potential treatment strat-egy in cardiovascular disease; Aleksandra Antonczyk; Malgorzata Sajek; Martyna Plens-Galaska; Joanna Wesoly; Hans Bluyssen

P1.2 Effect of evening primrose extract on the thymidylate synthase in the aspect of its anticancer properties in malignant pleural mesothelioma treatment.; Małgorzata Chmielewska-Kassassir; Dorota Szczęsna; Małgorzata Bukowiecka-Matusiak; Lucyna A. Woźniak

P1.3 Diminished attachment of Helicobacter pylori to gastric epithelial cells by BCG-Onko mycobacteria; Maciej Chyb; Agata Tomaszewska; Weronika Gonciarz; Krzysztof Hinc; Michał Obuchowski; Magdalena Chmiela

P1.4 First in Poland patient-derived xenograft platform for preclinical studies in oncology; Magdalena Cybulska; Michał Kopczyński; Zuzanna Sandowska-Markiewicz; Małgorzata Statkiewicz; Aleksandra Grochowska; Michalina Dąbrowska; Jakub Karczmarski; Agnieszka Paziewska; Marta Gajewska; Michał Mikula; Jerzy Ostrowski

P1.5 Brexpiprazole-inspired new, hybrid ligands demonstrating dual activity against serotonin 5-HT1A/5-HT7 receptors obtained by eco-friendly synthsesis method; Anna Drabczyk; Jolanta Jaśkowska; Przemysław Zaręba; Michał Rębiś; Damian Kułaga; Grzegorz Satała

P1.6 Anticancer activity of novel synthetic peptide δm4 in human melanoma cells; Estefania Fandiño; Gloria Santa-González; Edwin Patiño; Mauricio Camargo; Marcela Manrique-Moreno

P1.7 Development of AML disseminated models in mice to support drug dis-covery.; Elzbieta Fiedor; Marta Obacz; Michal Mikula; Magdalena Cybulska; Marion Chapellier; Aniela Golas; Michal Kopczynski; Przemyslaw Juszczynski; Jacek Stępniewski; Milena Mazan; Tomasz Rzymski

P1.8 δ-tocotrienol and bixin are the main responsible for the anti-stress activity of an achiote extract; Darío Gómez-Linton; Silvestre Alavez; Arturo Navarro-Ocaña; Luis Pinzón-López; Laura J. Pérez-Flores*

P1.9 Epigenetic modifications of histones as new therapeutic targets in perio-dontal; Aleksander M Grabiec; Katarzyna B Lagosz; Sławomir Dudek; Justyna M Macina; Jan Potempa

P1.10 Chimeric Hepatitis B/Hepatitis C virus like particles as a potential bivalent vaccine against viral hepatitis.; Katarzyna Grzyb; Anna Czarnota

POSTER NUMBER

TITLE, AUTHORS

20

P1.11 Mechanisms of the attenuation of angiotensin II-induced cardiac hypertro-phy by pharmacological inhibition of sphingosine kinase 1; Ewelina Józefczuk; Ryszard Nosalski; Blessy Saju; Eva Crespo; Szczepaniak Piotr; Tomasz Jan Guzik; Mateusz Siedliński

P1.12 Mycelial cultures of edible mushrooms as a source of potentially bioavailable phenolic compounds and bioelements; Katarzyna Kała; Agnieszka Szewczyk; Kornelia Szczurek; Beata Ostachowicz; Bożena Muszyńska

P1.13 Computer-aided insights into structure-activity relationship of novel hexyl arylpiperazines based on phthalimide, isatin and saccharin scaffold; Kułaga Damian; Jolanta Jaśkowska; Przemysław Zaręba; Anna Drabczyk; Grzegorz Satałab

P1.14 Targeting Keap1 in ageing endothelium – is it a friend or a foe?; Aleksandra Kopacz; Damian Kloska; Bartosz Proniewski; Dominik Cysewski; Nicolas Personnic; Jozef Dulak; Alicja Jozkowicz; Anna Grochot-Przeczek

P1.15 LifeGel - innovative technology for 3D cell cultures; Marcin Krzykawski

P1.16 Antitumor activity of OAT compounds in a multimodeling study; Katarzyna Laskowska-Kaszub; Mykola Zdioruk; Joanna Wojsiat; Anna Mietelska-Porowska; Sylwia Olejniczak; Stanisław Pikul; Jakub Golab; Urszula Wojda

P1.17 Application of human mesenchymal stem cell for repairing of damaged human aortic endothelial cell; Wen-Chien Lee

P1.18 Molecular mechanisms of peripheral neuropathy induced by bortezomib and lenalidomide: novel evidence for the miRNA – mRNA interaction involvement.; Karolina Łuczkowska; Dorota Rogińska; Zofia Litwińska; Edyta Paczkowska; Christian Andreas Schmidt; Bogusław Machaliński

P1.19 Oncolytic and Biophysical Evaluation of the Synthetic Peptide ΔM4 as a Potential Agent in the Treatment of the Skin Cancer; Marcela Manrique-Moreno; Veronica Tamayo; Gloria Santa; Edwin Patiño; Mauricio Camargo; Malgorzata Jemiola-Rzeminska; Kazimierz Strzalka

P1.20 Comparison of in vitro efficiency to the in silico prediction of obtaining ge-netic modifications using the CRISPR/Cas9 system for xenotransplantation purposes; Natalia Mazurkiewicz; Magdalena Hryhorowicz; Ryszard Słomski

P1.21 Micromycetes from the genus aspergillus – producers of proteinases with human hemostasis proteins activitysystem; Alexander Osmolovskiy;

POSTER NUMBER

TITLE, AUTHORS

21

Elizaveta Rukavitsyna; Anastasia Orekhova; Svetlana Timorshina

P1.22 Correction of bahavioral deficits and reduction of inflammation under the influence of genistein in R6/1 mice: comprehensive research on a new therapeutic approach in Huntington disease; Karolina Pierzynowska

P1.23 Combined Pan-STAT and STAT-independent characteristics of STATTIC as a novel treatment strategy of atherosclerosis; Martyna Plens-Gałąska; Małgorzata Sajek; Aleksandra Antończyk; Anna Piaszyk-Borychowska; Hans AR Bluyssen

P1.24 Macromolecular crowding effects on enzymatic activity. The case of the hepatitis C virus NS3/4A protease.; Agnieszka Popielec; Paweł Kowalski; Monika Wojciechowska; Joanna Trylska

P1.25 Biotechnological methods of enrichment of natural phosphatidylcholine with ferulic and 3,4-dimethoxy cinnamic acids; Magdalena Rychlicka; Natalia Niezgoda; Anna Gliszczyńska

P1.26 Deregulated apoptosis of neutrophils as a potential mechnism underlying the pathobiology of periodontitis; Maja Sochalska; Maja Sochalska; Jan Potempa; Magdalena Stanczyk; Maria Uzarowska

P1.27 Discovering the function of dystrophin and utrophin in cell signaling and its role in Duchenne muscular dystrophy pathogenesis; Alicja Starosta; Jeffrey S. Chamberlain; Patryk Konieczny

P1.28 VGVAPG peptide activate authophagy in mouse cortical astrocyte and human neuroblastona (SH-SY5Y) cell line; Konrad A. Szychowski; Klaudia Dachowska; Jakub Tobiasz; Jan Gmiński

P1.29 Possible link between Helicobacter pylori CagA /TNFα receptor and inflammatory response due to molecular mimicry; Agata Tomaszewska; Maciej Chyb; Weronika Gonciarz; Magdalena Chmiela

P1.30 Delivery of peptide nucleic acids into bacterial cells by vitamin B12 and future applications of their conjugations in antibacterial therapy; Monika Wojciechowska; Marcin Równicki; Aleksandra Wierzba; Dorota Gryko; Joanna Trylska

P1.31 A new sonochemical method for the synthesis of tricyclic antipsychotic drugs; Przemysław Zaręba; Jolanta Jaśkowska; Damian Kułaga; Anna K. Drabczyk; Przemysław Jodłowski

P1.32 Venlafaxine affects expression of APEX1, OGG1 and EXOG in amygdala in the chronic mild stress model of depression.; Sylwia Ziółkowska; Katarzyna Białek; Piotr Czarny; Mariusz Papp; Janusz Szemraj; Tomasz Śliwiński

POSTER NUMBER

TITLE, AUTHORS

22

Session 2 Plant breeding innovation

P2.1 CRISPR/Cas9 constructs evaluation for PHS-specific loci in Triticale; Michalski Krzysztof

P2.2 Macronutrients in grass plants and its effect on seed yield; Grzegorz Żurek; Kamil Prokopiuk; Danuta Martyniak; Eugeniusz Paszkowski; Urszula Woźna - Pawlak; Maciej Jurkowski

Session 3 Materials for biomedical applications

P3.1 Peptide hybrid scaffolds with proregenerative properties.; Maria Dzierżyńska; Justyna Sawicka; Milena Deptuła; Michał Pikuła; Martyna Fularczyk; Piotr Sass; Paweł Sosnowski; Paweł Sachadyn; Barbara Peplińska; Stefan Jurga; Zuzanna Pietralik; Maciej Kozak; Sylwia Rodziewicz-Motowidło

P3.2 Effect of ECM stiffness on human cardiac fibroblast morphology and func-tion; Sandra González Lana; Sara Oliván; Hennie Heida; Rosa Monge; Carlos Sánchez Somolinos; Begoña López; Aránzazu González; Ignacio Ochoa

P3.3 Three-dimensional graphene-loaded microfibers/hydrogel scaffolds for tissue engineering; Karolina Kosowska; Karolina Kosowska; Patrycja Domalik-Pyzik; Jan Chłopek

P3.4 The optimization of the quantitative and qualitative composition of multiple emulsions for biomedical applications; Magdalena Malinowska; Małgorzata Miastkowska; Elwira Lasoń; Grzegorz Kurowski

P3.5 Evaluation of the biosafety and bioavailability of the dendrimer – neurotro-phin-4 complex for potential use in retinal degenerative diseases – in vitro study; Dorota Rogińska; Maria Dąbkowska; Anna Sobuś; Zofia Litwińska; Karolina Łuczkowska; Bogusław Machaliński

P3.6 UAMME of Bidens tripartite as a rich source of chlorogenic acid; Elzbieta Sikora; Karolina Sliwa; Agnieszka Niewiadomska; Jan Ogonowski

P3.7 The release of copper tripeptide-1 from different kind of vehicles; Sikora Elżbieta; Michał Dymek

P3.8 Amplification-expression technology for construction of concatemeric DNA and proteins for novel biomaterials, biomedical and industrial applications.; Żebrowska Joanna

Session 4 Small and long nucleic acids therapeutics

P4.1 The function of two plasma microRNAs identified as potential biomarkers

POSTER NUMBER

TITLE, AUTHORS

23

of early stage Alzheimer’s disease; Katarzyna Laskowska-Kaszub; Siranjeevi Nagaraj; Aleksandra Fesiuk; Urszula Wojda

P4.2 MiRNAs and angiogenesis-regulating factors in plasma of CML patients be-fore and after TKI treatment initiation; Zofia Litwinska; Karolina Luczkowska; Anna Sobus; Dorota Roginska; Ewa Pius-Sadowska; Edyta Paczkowska; Michal Gniot; Krzysztof Lewandowski; Grzegorz Helbig; Boguslaw Machalinski

Session 5 Plant’s clinic

P5.1 Microshoot and callus cultures of Schisandra henryi as a source of phenol-ic acids - compounds of high importance in pharmacy and cosmetology; Agnieszka Szopa; Karolina Jafernik; Magda Barnaś; Halina Ekiert

P5.2 Development of multiplex real-time RT-PCR for simultaneous detection of potato viruses and potato tuber spindle viroid in potato seed tubers; Agata Kaczmarek; Izabela Jadach-Żebrowska; Anna Pawłowska; Mateusz Mielczarek; Krzysztof Treder

P5.3 Colorimetric detection of potato virus Y by Loop-mediated isothermal amplification of nucleic acids (LAMP) as an example of a development point-of-care test for potato viruses.; Mateusz Mielczarek; Anna Pawłowska; Agata Kaczmarek; Krzysztof Treder

P5.4 Detection of the crucial potato viruses in different potato tissues by immu-nological and molecular methods; Anna Pawłowska; Mateusz Mielczarek

P5.5 Defective interfering RNAs associated with Tomato black ring virus genome as a potential tools to protect plant against the virus; Aleksandra Zarzyńska-Nowak; Beata Hasiów-Jaroszewska; Daria Budzyńska; Julia Minicka

Session 6 Organoids and organs on chips

P6.1 Role of heme oxygenase-1 in maturation and binucleation of cardiomyo-cytes derived from human induced pluripotent stem cells.; Mateusz Jeż; Alicja Martyniak; Kalina Andrysiak; Alan Kania; Łukasz Chrobok; Katarzyna Palus-Chramiec; Alicja Józkowicz; Marian H. Lewandowski; Jacek Stępniewski; Józef Dulak;

Session 7 Environmental and industrial biotechnology in circular economy

P7.1 Complete genome sequence of Enterobacter sp. LU1; Szczerba Hubert; Karolina Dudziak; Zdzisław Targoński

POSTER NUMBER

TITLE, AUTHORS

24

Session 8 Microbial biotechnology and nanotechnology

P8.1 Genetic transformation of carrot (Daucus carota L.) mediated with carbon and gold nanoparticles; Rafal Baranski; Pavel Chaloupsky; Miron Gieniec; Eliska Sedlackova; Magdalena Klimek-Chodacka; Dalibor Huska

P8.2 Expanding the genetic transformation toolbox in Chlamydomonas rein-hardtii by nanoparticle-mediated molecular cargo delivery; Pavel Chaloupsky; Magda Barinkova; Eliska Sedlackova; Milica Gagic; Dalibor Huska

P8.3 (Phyto)remediation of arsenic contaminated soil using arsenite-oxidizing bacteria.; Klaudia Debiec-Andrzejewska; Tomasz Krucon; Maria Dabrowska; Katarzyna Piatkowska; Lukasz Drewniak

P8.4 Detoxification of selected N-heterocyclic compounds by the soil fungus Trichoderma citrinoviride; Aleksandra Felczak; Marta Nowak; Katarzyna Lisowska

P8.5 Application of leaf litter from a pocket park for fungal laccase production; Aleksandra Góralczyk-Bińkowska; Andrzej Długoński; Jerzy Długoński

P8.6 Application of Myrothecium sp. laccase for the elimination of industrial dyes; Aleksandra Góralczyk-Bińkowska; Anna Jasińska; Jerzy Długoński

P8.7 Microwave-assisted pretreatment of maize distillery stillage in the produc-tion of cellulosic ethanol.; Kłosowski Grzegorz; Dawid Mikulski; Beata Koim-Puchowska; Aleksandra Menka

P8.8 Autochthonous bacteria and non-conventional yeasts for treatment of anaerobic sludge digester supernatants generated upon thermophilic and mesophilic hydrogen fermentation of sugar beetroot pulp; Małgorzata Hałat-Łaś; Sebastian Borowski; Paweł Kaszycki

P8.9 Comparison of acetyl diacylglycerols from Euonymus europaeus and recombinant Yarrowia lipolytica; Jaroslav Hambalko; Peter Gajdoš; Patrícia Zuskáčová; Tatiana Klempová; Milan Čertík

P8.10 Successful uses of a bacterial isolate for the elimination of a non-biode-gradable water pollutant; Sabra Hemidouche; Lidia Favier; Abdeltif Amrane; Adrian Augustyniak; Zahra Sadaoui

P8.11 Assessment of toxicity during biodegradation of selected endocrine dis-ruptors; Tomasz Janicki; Jerzy Długoński; Mariusz Krupiński

POSTER NUMBER

TITLE, AUTHORS

25

P8.12 Practical review of molecular methods for differentiation and identification of bacteria belong to L. casei group at genus, species and strain level.; Piotr Jarocki; Elwira Komoń-Janczara; Agnieszka Glibowska; Michał Dworniczak; Oleksandr Kholiavskyi

P8.13 Bioethanol production from wheat and rye stillages after microwave-assist-ed pretreatment.; Grzegorz Kłosowski; Dawid Mikulski

P8.14 Screening of Bacillus subtilis natto strains for the ability to synthesis of biosurfactants.; Beata Koim-Puchowska; Grzegorz Kłosowski; Dawid Mikulski; Aleksandra Menka; Joanna Dróżdż-Afelt

P8.15 Evaluation of the ability of native Bacillus subtilis natto strains to produce

surfactin.; Beata Koim-Puchowska; Grzegorz Kłosowski; Dawid Mikulski; Aleksandra Menka; Joanna Dróżdż-Afelt

P8.16 Biotechnological production of fumaric acid based on co-utilization strate-gy of crude glycerol and glucose-fructose syrup; Elwira Komoń-Janczara

P8.17 An endophytic wheat’s isolates produce metabolites that have a positive effect on the physiology of wheat; Agnieszka Kuźniar; Kinga Włodarczyk; Magdalena Staniszewska; Ilona Sadok; Jarosław Grządziel; Karolina Furtak; Małgorzata Woźniak; Anna Gałązka; Agnieszka Wolińska

P8.18 Characteristic of antifreeze proteins produced by psychrophilic yeast from Glaciozyma martini species; Edyta Majewska; Aneta Białkowska

P8.19 Evaluation of the possibility of using lignocellulosic material in the form of brewer’s spent grain subjected barothermic pretreatment for the produc-tion of second-generation ethanol.; Aleksandra Menka; Dawid Mikulski; Grzegorz Kłosowski; Beata Koim - Puchowska; Joanna Maria Dróżdż - Afelt

P8.20 Selection and optimization of process parametrs of enzymatic hydrolysis of cellulose from brewer’s spent grain subjected to barothermic pretreat-ment in an acidic environment.; Aleksandra Menka; Dawid Mikulski; Grzegorz Kłosowski; Beata Koim - Puchowska; Joanna Maria Dróżdż - Afelt

P8.21 Use of dilute sulfuric acid pretreatment of distillery stillage in the produc-tion of cellulosic ethanol.; Dawid Mikulski; Grzegorz Kłosowski

P8.22 Efficiency of lignocellulose degradation after microwave-assisted pretreatment of maize distillery stillage with the use of dilute sulfuric acid.; Dawid Mikulski; Grzegorz Kłosowski; Aleksandra Menka; Beata Koim-Puchowska

P8.23 Effect of 2,4-D on the permeability of the Trichoderma harzianum cell

POSTER NUMBER

TITLE, AUTHORS

26

membrane; Julia Mironenka; Przemysław Bernat; Sylwia Różalska

P8.24 Designed hammerhead ribozyme as a potential antibacterial; Joanna Miszkiewicz; Ksenia Maximova; Maciej Łukaszewicz; Edward Darżynkiewicz; Joanna Trylska

P8.25 The elimination of preservatives present in personal care products by fila-mentous fungi; Marta Nowak; Katarzyna Zawadzka; Katarzyna Lisowska

P8.26 Occurrence and ecological risk of preservatives present in personal care products; Marta Nowak; Katarzyna Zawadzka; Katarzyna Lisowska

P8.27 Determination of destruxins in Metarhizium sp. by liquid chromatography – mass spectrometry technique; Monika Nowak; Sylwia Różalska

P8.28 Potential of circular economy from palm oil mill wastes: Composting case study; Poonsuk Prasertsan; Werayut Juansai; Suteera Prasertsan

P8.29 Post-fermentation sludge liquid: environmental risk and a novel treatment method based on the sequential use of microalgae and activated sludge; Kinga Regdos; Małgorzata Hałat-Łaś; Przemysław Malec; Paweł Jedynak; Jan Burczyk; Paweł Kaszycki

P8.30 Antibacterial activity of chitosan-metal oxide films; Natalia Wrońska; Marta Nowak; El Kadib Abdelkrim; Katarzyna Lisowska

P8.31 (Bio)reclaim of metals from effluents from hydrometallurgical urban mining of E-wastes; Zhendong Yang; Lukasz Drewniak; Jacek Redka; Witold Uhrynowski; Klaudia Debiec-Andrzejewska

P8.32 Enhancement of antimicrobial activity by co-administration of titanium oxide nanoparticles and chosen antibiotics; Katarzyna Zawadzka; Marta Nowak; Aleksandra Felczak; Natalia Wrońska; Mariusz Krupiński; Katarzyna Lisowska

P8.33 Production of value added materials from pine needle biomass using biorefinery approach; Parvez Singh Slathia; Preeti Sharma; Vinaik Raina; Nisha Sharma; Vibharish Raina

Session 10 Gene and cell therapies

P10.1 Induced pluripotent stem cells-derived cardiomyocytes for studies on the mechanism of cardiomyopathy in Duchenne muscular dystrophy; Kalina Andrysiak; Jacek Stępniewski; Mateusz Jeż; Łukasz Chrobok; Katarzyna Palus-Chramiec; Paweł Ferdek; Marian Lewandowski; Józef Dulak

POSTER NUMBER

TITLE, AUTHORS

27

P10.2 The effect of HO-1 overexpression on regenerative potential of murine and human muscle progenitor cells; Iwona Bronisz-Budzyńska*; Urszula Głowniak*; Asier Laria Caballero*; Kalina Andrysiak; Magdalena Kozakowska; Jacek Stępniewski; Józef Dulak

P10.3 Development of new HGPS cellular model and evaluation of genetic drugs efficiency for HGPS therapy.; Volha Dzianisava; Katarzyna Piekarowicz; Magdalena Machowska; Ryszard Rzepecki

P10.4 Generation of PAX7-GFP hiPSC line using CRISPR/Cas9 gene editting method; Radosław Grochowski; Jacek Stępniewski; Józef Dulak

P10.5 Genome instability and depletion of cardiac progenitor and resident cells in Duchenne muscular dystrophy; Šárka Jelínková; Franck Aimond; Amanda Finan-Marchi; Valerie Scheuermann; Petr Fojtík; Yvonne Sleiman; Gilles Carnac; Alain Lacampagne; Petr Dvorak; Albano Meli; Vladimir Rotrekl

P10.6 Slow divisions of murine melanoma cells mark the population with melanoma initiating cells properties; Anna Kusienicka; Karolina Bukowska-Strakova; Maciej Cieśla; Witold Nowak; Iwona Bronisz-Budzyńska; Agnieszka Seretny; Monika Żukowska; Jan Wolnik; Józef Dulak; Alicja Józkowicz

P10.7 Human induced pluripotent stem cells differentiated to endothelial cells as a tool for studying the role of angiogenesis in Duchenne muscular dystro-phy; Agnieszka Loboda; Katarzyna Kaziród; Kinga Rusin; Paulina Podkalicka; Olga Mucha; Neli Kachamakova-Trojanowska; Kalina Andrysiak; Jacek Stępniewski; Józef Dulak

P10.8 The role of miR-378a in maturation of human induced pluripotent stem cells-derived cardiomyocytes.; Alicja Martyniak; Solène Coste; Benjamin Motais; Jacek Stępniewski; Józef Dulak

P10.9 The involvement of heme oxygenase-1 in the angiogenesis-related altera-tions in a murine model of Duchenne muscular dystrophy; Olga Mucha; Paulina Podkalicka; Mateusz Tomczyk; Kinga Rusin; Iwona Bronisz-Budzyńska; Magdalena Kozakowska; Alicja Józkowicz; Józef Dulak; Agnieszka Łoboda

P10.10 Attenuated dystrophic phenotype in mdx mice lacking microRNA-378 is associated with decreased inflammation, fibrosis and systemic metabolic alterations; Paulina Podkalicka; Olga Mucha; Magdalena Kozakowska; Katarzyna Pietraszek-Gremplewicz; Iwona Bronisz-Budzyńska; Jerzy Ostrowski; Michał Mikuła; Ewelina Pośpiech; Alicja Józkowicz; Agnieszka Łoboda; Józef Dulak

P10.11 Expression of miR-16-5p and miR-9-5p in CSF of ALS patients after au-

POSTER NUMBER

TITLE, AUTHORS

28

tologous transplantation of Lin- cells; Anna Sobuś; Bartłomiej Baumert; Monika Gołąb-Janowska; Zofia Litwińska; Edyta Paczkowska; Karolina Łuczkowska; Alicja Zawiślak; Sławomir Milczarek; Bogumiła Osękowska; Przemysław Nowacki; Bogusław Machaliński

P10.12 Stem cell research, fundamental rights and patent law – how scientific progress influences patentability; Tomasz Zimny

Session 11 Plants and environmental stress

P11.1 Insights into The Genetic Mechanism of Selenium (Se)’s Protective Effect in Brachypodium distachyon Plants Under Cadmium (Cd) Stress; M. Aydin Akbudak; Sukran Yildiz

P11.2 Callitriche cophocarpa as a model to study on arsenic phytobial remedi-ation of waters; Joanna Augustynowicz; Mikay Breet; Iwona Kamińska; Anna Kostecka-Gugała; Anna Kowalczyk; Dariusz Latowski; Agnieszka Baran

P11.3 High production of phenolic acids in shoot cultures of Aronia melanocarpa L. cultivated in PlantForm bioreactors; Halina Ekiert; Paweł Kubica; Adrianna Pałka; Agnieszka Szopa

P11.4 Dynamics of phenolic acids production in Aronia melanocarpa L. agitated shoot cultures during the growth cycles; Halina Ekiert; Paweł Kubica; Adrianna Pałka; Agnieszka Szopa

P11.5 Proteomic changes during the development of nematode-induced syncy-tium on tomato roots.; Marcin Filipecki; Marek Żurczak; Maciej Kotliński; Jarosław Olszewski; Wojciech Kurek; Magdalena Święcicka

P11.6 Carrot miniature-inverted-repeat-transposable-element-derived siRNAs in response to salinity stress; Dariusz Grzebelus; Alicja Macko-Podgórni; Magdalena Klimek-Chodacka; Kamil Szymonik; Rafał Barański; Aneta Łukasiewicz

P11.7 Development of an efficient and stable technique of genetic transformation of Coccomyxa subellipsoidea C-169.; Kinga Kania; Maksymilian Zienkiewicz; Anna Drożak; Elżbieta Romanowska

P11.8 Bacterial symbionts of water-starwort (Callitriche sp.) exhibit arsenic and chro-mium resistance; Anna Kowalczyk; Joanna Augustynowicz; Dariusz Latowski

P11.9 Differentially expressed miRNAs and their targets in soybean chilling stress; Jakub Kuczyński; Jakub Kuczyński; Agata Tyczewska; Joanna Gracz; Tomasz Twardowski

P11.10 Accumulation of flavonoids in agitated shoot cultures of three Hypericum perforatum L. cultivars ‘Elixir’, ‘Helos’ and ‘Topas’ during the short term growth cycles; Inga Kwiecień; Beata Wideł; Ludger Beerhues; Halina Ekiert

POSTER NUMBER

TITLE, AUTHORS

29

P11.11 Elicitation of agitated in vitro cultures of Scutellaria baicalensis L. by methyl jasmonate; Inga Kwiecień; Beata Kawka; Halina Ekiert

P11.12 Expression analysis of heat shock protein genes in carrot seedlings under salt stress; Kornelia Kwolek; Alicja Macko-Podgórni; Magdalena Klimek-Chodacka; Aneta Lukasiewicz; Rafal Baranski; Dariusz Grzebelus

P11.13 Salt stress-induced changes in differential gene expression profiles in toler-ant and sensitive carrot plants; Aneta Lukasiewicz; Alicja Macko-Podgórni; Magdalena Klimek-Chodacka; Dariusz Grzebelus; Rafal Baranski

P11.14 Role of disulfide bonds in maintaining secondary structure, ascorbate binding and activity of violaxanthin de-epoxidase.; Monika Olchawa-Pajor; Dariusz Latowski; Kazimierz Strzałka

P11.15 In vitro shoot cultures of Isatis tinctoria L. - establishment and growth con-dition; Jasmine Speranza; Inga Kwiecień; Salvatore Ragusa; Natalizia Miceli; Halina Ekiert

P11.16 Preliminary characteristics of microbiota of cadmium-contaminated soils upon phytoremediation with the common ice plant (Mesembryanthemum crystallinum); Marta Śliwa-Cebula; Paulina Supel; Monika Zankowicz; Zbigniew Miszalski; Paweł Kaszycki

P11.17 Gliphosate resistance trait traced in genomes of maize inbred lines; Agata Tyczewska; Medhat Helmy; Marek Żywicki; Joanna Gracz; Wojciech Karłowski; Tomasz Twardowski

P11.18 Antioxidant capacity of myxoxanthophyll (myxol 2’-dimethylfucoside) from cyanobacterium Synechocystis sp. PCC6803; Paweł Żbik; Przemysław Malec

P11.19 Bioaccumulation of selected macro- and microelements in microshoot cul-tures of Nasturtium officinale (watercress) Marta Klimek-Szczykutowicz; Agnieszka Szopa; Eliza Blicharska; Halina Ekiert

P11.20 Studies on the potential molecular markers of resistance to clubroot dis-

ease in Brassica plants Monika Markiewicz; Małgorzata Podwyszyńska

Session 12 Vaccines and Antivirals

P12.1 Berberine hampers influenza virus replication by inhibiting MAPK/ERK pathway; Paweł Botwina; Katarzyna Owczarek; Krzysztof Szczubiałka; Maria Nowakowska; Krzysztof Pyrć

P12.2 Characterization of Zika virus-like particles for vaccine purposes;

POSTER NUMBER

TITLE, AUTHORS

30

Gabriela Brzuska; Ewelina Król; Alicja Dziadosz; Bogusław Szewczyk

P12.3 In vitro verification of Zika virus NS3 protease inhibitors; Agnieszka Dąbrowska; Aleksandra Milewska; Joanna Ner; Piotr Suder; Krzysztof Pyrć

P12.4 Brown algae – the source of novel antiviral compounds; Katarzyna Owczarek; Magdalena Pachota; Aleksandra Synowiec; Artur Szczepański; Paweł Botwina; Aikaterini Koutsaviti; Elsi-Evangelia Andriotaki; Maria Harizani; Vassilios Roussis; Efstathia Ioannou; Krzysztof Pyrć

P12.5 Inhibitors of HSV-1 protease VP24 as potential drug candidates; Magdalena Pachota; Aleksandra Synowiec; Renata Grzywa; Jakub Iwanejko; Dominika Iwan; Elżbieta Wojaczyńska; Cameron Mackereth; Marcin Sieńczyk; Krzysztof Pyrć

P12.6 Identification of cellular molecules involved in the feline herpesvirus type 1 cell entry; Aleksandra Synowiec; Magdalena Pachota; Agnieszka Dąbrowska; Krzysztof Pyrć

P12.7 Betacoronaviruses – determinants of entry; Artur Szczepański; Katarzyna Owczarek; Krzysztof Pyrć

Session 13 Agribiotechnology

P13.1 Biological treatment of toxic waste effluent generated upon hydrogen fermentation of sugar beetroot pulp with the yeast Yarrowia lipolytica.; Kaszycki Paweł; M Hałat-Łaś; S. Borowski

P13.2 Application of natural plant extracts in reproduction and cryopreservation of bleeding heart; Dariusz Kulus; Natalia Miler

P13.3 Studies of the relationship between insecticides and entomopathogenic fungi - the possibility of their co-application; Anna Litwin; Justyna Nykiel-Szymańska; Cezary Tkaczuk; Mirosława Słaba; Sylwia Różalska

P13.4 Eco-friendly form of fungicide; Małgorzata Miastkowska; Elżbieta Sikora; Alicja Michalczyk; Katarzyna Figacz

P13.5 Role of Myrtus communis L. essential oil in inhibition of AHL-mediated production of exopolysaccharides by food-associated Pseudomonas flu-orescens; Kamila Myszka; Natalia Sobieszczańska; Małgorzata Majcher; Anna Olejnik; Artur Szwengiel; Wojciech Juzwa

P13.6 Application of mtDNA for determining species of forensic traces.; Małgorzata Natonek-Wiśniewska; Anna Radko

POSTER NUMBER

TITLE, AUTHORS

31

P13.7 mtDNA analysis for genetic identification of mealworm in meals for animal; Małgorzata Natonek-Wiśniewska; Piotr Krzyścin

P13.8 Application of multiplex microsatellite panel in alpaca (Vicugna pacos), llama (Lama glama) and llama x alpaca hybrids in Poland; Angelika Pod-bielska; K. Piórkowska; A. Radko

P13.9 Acceptance of GM food among Krakow students; Małgorzata Pokrywka; Paweł Jagielski; Patrycja Krynicka; Małgorzata Małek; Małgorzata Maraj; Klaudia Szewc; Ewa Świndryk; Justyna Władarz; Bogdan Solnica

P13.10 Analysis of polymorphism 22 STR markers used for parentage control in pigeons in Poland; Anna Radko; Angelika Podbielska; Agnieszka Szumiec

P13.11 Molecular docking studies evaluating anti quorum sensing properties of methyl eugenol-rich Tarragon essential oil against Pseudomonas psychro-phila; Natalia Sobieszczańska; Kamila Myszka; Małgorzata Majcher; Artur Szwengiel

P13.12 Survivability of lactobacilli in crude juices of selected berry fruits; Klaudia Spórna; Anna Kostecka-Gugała; Petryszak Przemysław Petryszak; Paweł Kaszycki

P13.13 Influence of the dry matter content in fermentation medium on the ethanol yield; Ewelina Strąk-Graczyk; Maria Balcerek

P13.14 Influence of the pH of fermentation medium on the quality of obtained distil-lates; Ewelina Strąk-Graczyk; Maria Balcerek; Katarzyna Pielech-Przybylska; Urszula Dziekońska-Kubczak; Piotr Patelski

P13.15 Biotechnology patenting in the European Union countries: Poland example; Ewa Woźniak;

P13.16 Evaluation of genetic diversity within gooseberry cultivars (Ribes grossular-ia subgenus Grossularia) with the use of AFLP technique; Danuta Wójcik; Danuta Kucharska

P13.17 Effect of photoperiod and LED light irradiation on floral induction, morphol-ogy and photosynthetic activity of strawberry (Fragaria x ananassa Duch.); Danuta Wójcik; Monika Markiewicz; Bożena Matysiak; Iwona Sowik

P13.18 Genome-wide association study of Brassica napus cultivars during Alter-naria brassicicola infection; Violetta K. Macioszek; Rachel Wells; Tomasz Jęcz; Henk-jan Schoonbeek; Michal Macioszek; Chris Ridout; Iwona Ciereszko; Andrzej K. Kononowicz

32

EXCELLENCE IS:

Complete Process Control

Hamilton Bonaduz AG | CH-7402 Bonaduz, Switzerland contact.pa.ch@hamilton.ch | www.hamiltoncompany.com 30YEARS Hamilton

Process Analytics

CellDensity pH DO Cond

Hamilton offers measuring solutions for a complete measurement loop, including sensors for pH, dissolved oxygen, conductivity, viable and total cell density and ORP. Our sensors and accessories are characterized by proven quality and outstanding performance, backed by many years of engineering and manufacturing expertise in innovative design.

NewIncyte

Arc

33

EXCELLENCE IS:

Complete Process Control

Hamilton Bonaduz AG | CH-7402 Bonaduz, Switzerland contact.pa.ch@hamilton.ch | www.hamiltoncompany.com 30YEARS Hamilton

Process Analytics

CellDensity pH DO Cond

Hamilton offers measuring solutions for a complete measurement loop, including sensors for pH, dissolved oxygen, conductivity, viable and total cell density and ORP. Our sensors and accessories are characterized by proven quality and outstanding performance, backed by many years of engineering and manufacturing expertise in innovative design.

NewIncyte

Arc

A&A Biotechnologywww.aabiot.cominfo@aabiot.com

A&A Biotechnology is a Polish biotech company that develops and produces innovative tools for the life science industry. It was founded in 1993 by its current CEO Adam Burkiewicz, PhD. The company has its own research laboratories and production acilities.A&A Biotechnology offer includes DNA and RNA isolation kits, PCR and reverse transcription reagents, cloning and transformation reagents, molecular biology reagents and services. The company also have facilities able to produce high volume of molecular biology – grade enzymes.A&A Biotechnology products and services are mainly used by scientific and diagnostic laboratories at universities, research institutes, veterinary laboratories, health services, laboratories for environmental analyzes, forensic laboratories and other life science companies.In addition, as a specialist life science company with its own R&D and production department, we are able to tailor our products and solutions to meet client’s individualn needs.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GENETYKA sp. z o.o. sp. k. SPONSORwww.analitykgenetyka.plbiuro@analitykgenetyka.pl

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

APEXEL CO., LTDwww.apexel.krntw314@naver.com

1. Efficacy, absorption and stability of NANO particles

1) EfficacyThe micron sized particles are almost not absorbed practically in the body. However, the NANO pulverized particles are mostly easily broken, digested and absorbed in the body. The specific merit of the NANO particles pulverized in our mill is to especially maintain the specific “as is” natural TASTE, INCENSE, and NUTRITION of the materials.

2) StabilityNANO foodstuffs are absolutely safe.(Practically, there has been a lots of nano-foodstuffs and nano-cosmetic items from old ages. As an example, our NANO pulverized particles, are as absolutely safe as such various drinking beverages like water, milk, orange juice and other extracted organic materials, and such cosmetic items like nutrition cream, skin lotion, perfume and etc. because the particles sizes pulverized in our mill are equivalent in particle sizes to those sizes mentioned above.

SPONSORS AND EXHIBITORS

34

2. Advantage of NANO Calcium compare to other oyster calcium or synthetic calcium carbonateNo calcium supplement available in the marketplaces can recuperate Osteoporosis.But only the NANO calcium produced in our mill can recuperate Osteoporosis perfectly. Accordingly, the remarkable ripple effect is extended on such symptoms as arthritis, infertility, hepatitis B, diabetes and helps rejuvenation highly.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Bayer SPONSOR

Bayer is an innovation company with a more than 150-year history with core competen-cies in the Life Science fields of health care and agriculture. Our scientific successes are intended to help improve people’s lives. We address some of the world’s most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. How will we feed up to ten billion people by 2050 while contending with the impact of climate change? These are the challeng-es that we are looking to address. In line with our corporate purpose “Science for a better life,” we are driving the development of better medicines and the production of high-quality food through innovative solutions. Alongside our goal of achieving eco-nomic success, we also seek to make a responsible contribution to the United Nations Sustainable Development Goals of “Good Health and Well-Being” and “Zero Hunger” within the scope of our entrepreneurial possibilities.We strive to meet our responsibility to the environment and society, and to continuously develop our businesses such that they assume leadership positions in their respective industries and segments to achieve long-term success for our company. We invest in a diversified portfolio of strong businesses that create value. Our efforts are sustained by our employees and our core competencies of innovation, customer focus, quality, process excellence and portfolio management.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BIOKOM SILVER SPONSORwww.biokom.com.plinfo@biokom.com.pl

Our company has been established on the market in 1995. We are distributing more than 20 renowned producers. Our offer aims at biological and biomedical sciences. We supply reagents, equipment and laboratory consumables. Our selection includes EIA assays, antibodies for all immunological techniques, purified proteins, chemical compounds and enzymes. Large part of our offer is contributed to laboratory microplate equipment: automated microscopes, multimode readers, fluorescence and absorption readers, spectropho-tometers, microplate washers and CO2 incubators, freeze dryers, automatic pipettes. The complementary part of our offer is plastic consumables useful in molecular biology, cell and tissue cultures and immunology.

35

BIOMEDICA POLAND SP. Z O.Owww.bmgrp.ploffice@bmgrp.pl

Biomedica Poland is one of the major distributor for companies from life science market.We offer broad range of products, from daily used products (antibodies, protein gels, Elisa, proteins, primary cells and many more) to sophisticated techniques like Digital Spatial Profiling or Molecule Counting. Combination of good quality products covering different fields of research (immunology, cancer, cell biology, etc) and reliable support offered by Biomedica makes the company unique on the market.We are proud to be distributor of companies like Promocell, Qiagen, Nanostring, (and many more!) but we also produce our own Elisa for specific parameters used in clinics.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Bio Rad SILVER SPONSORwww.www.bio-rad.comPoland_Reception@bio-rad.com

Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research (LSG) and clinical diagnos-tic (CDG) markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that in-clude food safety and environmental quality.Life Science Research (LSG)Bio-Rad is among the top five life science companies in the world, providing instru-ments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and man-ufacture, food safety, and science education. Our products and solutions are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.Digital BiologyOffering unrivaled precision and absolute quantification of target DNA or RNA mol-ecules, our unique Digital Droplet technology partitions samples into thousands of microfluidic “droplet” test tubes, providing extremely sensitive and accurate digital answers for life science research, clinical diagnostics, as well as environmental mon-itoring and food safety testing.

36

Bio-Technewww.bio-techne.cominfo@bio-techne.com

Bio-Techne unites the trusted brands: R&D Systems, Novus Biologicals, Tocris, ProteinSimple and Advanced Cell Diagnostics (ACD). Over 350,000 products: • Proteins and Antibodies – Validated antibodies in many formats, recombinant,

natural proteins and custom services. • Small molecules – High quality, high purity and fully annotated novel small molecules

and peptides.• Protein analysis platforms – Simple PlexTM, Simple WesternTM, Single-Cell Westerns

and iCETM platforms. • ELISAs and Luminex® - Quantikine® and DuoSet® ELISAs, bead-based multiplex

assays and Luminex® instruments.• RNA ISH – Advanced in situ hybridization (ISH) assay RNAscope® Technology

to identify target genes in any species, in any tissue.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Centre of Technology Transfer, Cracow University of Technologywww.transfer.edu.pl, www.pk.edu.plsekretariat@transfer.edu.pl

Cracow University of Technology has over 70-year-old tradition of educating engineers, modernity and openness to change as well as hard work on the improve-ment of the Polish scientific and technical thought. CUT ensures the highest scientific level and professional collaboration with industry. Many of the nearly 1 200 researchers are outstanding professionals who participate in intercollegiate and international research teams. Their knowledge and expertise allow our university to maintain the high position in Polish and international scientific community.Center for Technology Transfer at CUT Cracow University of Technology. Main fields of our operation are:• sale and lease of CUT intellectual property,• S2B and B2B technology transfer,• services supporting SME development.Center for Technology Transfer focuses on implementation of CUT’s research results to the industry. Our Center has an insight knowledge about the realities of the commercialization process, and thanks to active collaboration with entrepreneurs can clearly identify needs and technical and business expectations of the industry.

37

Curiosis Inc.www.curiosis.co.krlayla@curiosis.co.kr

Curiosis’s expert team of scientists and engineers are dedicated to develop high efficiency instruments which allow the researchers to challenging their progress im-provement.• Establishment date: 1 February 2015• Head office: Seoul, South Korea• Employee: 28 (R&D ratio more than 40%)• Main products: Instrument & Disposable (ISO 9001;13485)1. FACSCOPE B: Automatic cell counter2. Celloger Mini: Live Cell Imaging System3. C-Slide: Disposable hemocytometer

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diCELLawww.dicella.coma.kubica-misztal@dicella.com

diCELLa is a bionformatic company focus on computer software and solutions for analysis of microscope images. Custom developed algorithms, the latest machine learning methods and deep neural networks allow us to open new possibilities in the area of data and image analysis. diCELLa has also developed proprietary security system for laboratories using blockchain technology which not only supports data encryption but also responds to the polish restiction of Personal Data Protection Act, the RODO. Ouer software is used in industry and science allowing for great flexibility while minimizing working time and high efficiency.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Elsevier SPONSORwww.elsevier.comstjnlsemarketing@elsevier.com

Elsevier is a global information analytics business that helps institutions and profes-sionals advance healthcare, open science and improve performance for the benefit of humanity. At Elsevier, we publish more than 2,000 scientific research journals, in-cluding an excellent choice of Biotechnology titles, that offer a range of ways you can make your work open access.

38

Genos s.c.www.genos.com.plgenos@genos.com.pl

GENOS s.c. trading company is a distributor of laboratory media, reagents and equipment with emphasis on tissue culture products and molecular biology.We are the sole distributor of cell culture media of Biological Industries: classical media, FBS, supplements, special media for MSC, iPS, hESC (defined, xeno-free, serum-free system), cytogenetic products, etc.We offer tissue culture plastics of TPP: flasks, dishes, plates, pipettes, cryotubes, falcons, etc.In our portfolio you will find also kits for pharmacogenetics of Diatech Pharmacoge-netics, kits for the detection of viruses using ISH of PanPath, semen analysers of MES and medical devices of MRC.GENOS Non-Public Outpatient Clinic and Genetic Laboratory provide specialist tests and counselling in clinical genetics.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Hamilton Bonaduz AG SILVER www.hamiltoncompany.com SPONSORlklimczak@hamilton.ch

Hamilton Company specializes in the development, manufacturing and customiza-tion of precision measurement devices, automated liquid handling workstations, and sample management systems. Hamilton’s processes are optimized for quality and flexibility. Whether it’s a custom needle with a quick delivery time frame, a special length pH sensor, or a comprehensive solution to fully automate your assay workflow, trust that Hamilton products will always meet your needs.Hamilton Process Analytics covers the most important parameters in biopharma pro-ceses, such as pH, Dissolver Oxygen, Conductivity, Optical Density and Viable Cell Density. We push innovative solution into everyday life in the biotechnology and sup-port our Customers in every step of the process.

39

IRtech www.irtech.plinfo@irtech.pl

IRtech is distributor of Abberior STED and confocal microscopes, Nanonics BIO-AFM, Hidex microplate readers, SOL Instruments Raman confocal microscopes and Huygens software for microscopy images processing and analysis. IRtech company has also opened commercial super-resolution microscopy (STED) and molecular biology laboratory located at the Institute of Zoology, Jagiellonian Uni-versity, Cracow. We are offering possibility to image your samples at nanometer scale using high-end confocaland super-resolution STED microscope (Abberior). We provide complex help in planning and designing your fluorescence and confo-cal microscopy experiments as well as optimization of sample preparation process.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Kancelaria SILVER SPONSOR Chałas & Partners www.chwp.plchwp@chwp.pl

The CHWP Group specialises in legal and financial services for large business enti-ties. The world’s most significant and reputable brands are among our clients. Our advisors form an international team of experienced experts. Each of our offices offers access to the global expertise and the same top quality service. Specific sector of the economy? Perfect. Business in an exotic country? Superb. Business knows no limits. We are always close by.Chałas & PARTNERS is ranked among the leading law firms and strongest brands on the Polish competitive legal services market. With a strong focus on advising corpo-rate undertakings, the largest group of its clients includes multinational corporations. Our lawyers are globally-minded, our legal services are delivered through a single network of branch offices and associated law firms located in more than 20 countries all over the world. Our multinational team of lawyers offers its clients a world-class integrated legal advice.We have successfully advised clients on a number of projects, in particular, in ener-gy, chemical, pharmaceutical, logistics, IT, food, construction, banking and FMCG industries.

40

Lab-JOT Ltd. Sp.z o.o. Sp.k. SPONSORwww.labjot.com biuro@labjot.com

Lab-JOT for over 25 years supplies scientists and research institutes with reagents and laboratory equipment used in molecular biology research, including:• antibodies, ELISA kits and related products• restriction and modifying enzymes, polymerases, molecular cloning kits, NGS,

qPCR, RT-PCR• sample collection and preservation kits• DNA, RNA and protein isolation and purification kitsWe represent world’s leaders in the discovery and production of innovative reagents for life science research: Cell Signaling Technology and New England BioLabs.We offer reliable, fast and professional service to support and facilitate customer’s research goals. Our priority is customer satisfaction and we do our best to meet cus-tomers’ expectations.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MGI Tech Co., Ltd.

MGI Tech Co., Ltd. (referred to as MGI) adheres to the philosophy of “innovative wisdom to lead life science and technology” and is committed to being the core tool builder of technology for life science. Focusing on the R&D, production and sales of instruments, reagents and other related products in the fields of life scienc-es and medical health, MGI provides real time, whole picture and total solutions for the needs of human health and well-being, such as precision medicine, precision agriculture and precision health. It offers a complete digital biology device and system solution for the entire lifecycle.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Promega GmbH SPONSORpl_custserv@promega.comwww.promega.com

With a portfolio of more than 4,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in academic, industrial and government settings.Promega products are used by life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification. A cornerstone of Promega business practice is supporting customers, community and employees.

41

Roche Polska Sp. z o.o. SILVER SPONSORwww.roche.plpl.kontakt@roche.com

Roche Polska is a leading provider of innovative healthcare solutions. Roche has been helping physicians in Poland in their daily struggle for the health and well-being of patients for more than one hundred years. The Company also works with academ-ic and medical associations. Roche shares the view that the key areas influencing Poland’s development, innovation and science are particularly important, which is why we have been engaged in R&D activities for many years, making both areas a key element of our corporate social responsibility. Poland plays also an important role in the Roche product development strategy, participating in the majority of its international clinical trials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Sarstedt Sp.z o.owww.sarstedt.cominfo.pl@sarstedt.com

The SARSTEDT Sp. z o.o - a representative of a German manufacturer of medical and scientific equipment, offered for over 60 years worldwide.The company’s offer: products for cell culture and molecular biology, microtubes, pipette tips, petri dishes, measuring and serological pipettes, enclosed blood collection system, capillary blood collection system, prepared tubes, test tubes, containers for biological material, devices laboratory and equipment for the serological laboratory and blood donation centres.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Sartorius Poland Sp. z o.o.www.sartorius-polska.cominfo.pl@sartorius.com

The Sartorius Lab Products & Services Division is a broad-based premium supplier of high-quality laboratory instruments, high-grade consumables and excellent services. Our customers are from research and quality assurance laboratories of the pharmaceutical, chemical and food industries as well as from the academic sector. The product portfolio of our division focuses on high-value laboratory instruments, such as lab balances, pipettes and laboratory water purification systems. In laboratory weighing technology, our company ranks as the world’s second largest equipment supplier, and enjoys a strong position among the leading global suppliers for consumables, pipettes and laboratory water purification systems.

42

Sartorius Stedim

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharma ceutical industry around the world to develop and produce drugs safely, timely and economically. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions.”

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STI Bartosz Czajkowskiwww.sti.biz.ploffice@sti.biz.pl

STI is a Polish distributor of reagents and laboratory equipment. We offer laboratory reagents for research in immunology, molecular biology, and toxicology. Deliv-er antibodies, ELISA, protein, and vectors and other reagents for the laboratory world renowned manufacturers. For medical laboratories we offer products for IVD diagnostics. We also offer IVD antibodies for immunohistochemistry. We provide consulting, training and technical assistance in the selection of appropriate reagents for the determination of PCR and Real-Time PCR. All our products are certified medical devices. We advise on the preparation of research projects and provide laboratory services in the field of immunology, proteomics, molecular biology, analytical chemistry and environmental analysis. We provide a synthesis of peptides, recombinant proteins, antibodies, analysis using the matrix protein, immunohistochemical studies and many others.We only work with certified laboratories in Poland, Europe and the United States that employ cutting-edge laboratory techniques.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Sygnis Bio Technologieshttps://sygnis.pl/biobio@sygnis.pl

In Sygnis Bio Technologies we strive to provide our partners with the most inventive approach to bioengineering. We are a leading provider of scientific equipment on the Polish market, with a strong focus on high resolution live cell imaging and tissue engineering. Our portfolio combines a multitude of techniques i.e.: 3D bioprinting, biopatterning, live cell and super-resolution imaging.We are the only distributor of 3D bioprinting market leader, CELLINK, for Eastern Europe and bioprinting 3D solutions partner for “Bionic Pancreas” of FBiRN. We are one of a few experts in the field of 3D holotomographic imaging. We offer cutting edge technology to the scientific world, such as Cellink holographic multiphoton bioprinter - Holograph X.

43

TK Biotech Sp. Z o. o. Sp. K.www.tkbiotech.com.ploffice@tkbiotech.com.pl

TK BIOTECH company as a distributor of high quality laboratory equipment and reagents for research centers actively participates in development of biotechnology leading to new discoveries in research and diagnostics. We provide modern equipment and systems for researchers that significantly increase research capabilities while reducing costs. We supply laboratory equipment and reagents to most important scientific centers in Poland.Our position was built on collaboration and reliability. Our team consists of specialists in the field of molecular biology, biotechnology, biochemistry and biology, so we are able to provide our customers with professional consulting, support and assistance in choosing optimal solutions.We provide: consulting and specialist support for our clients, application trainings, professional technical service.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

UNIVERSITY OF GDAŃSKwww.en.ctt.ug.edu.pltto@ug.edu.pl

The research potential of the University of Gdańsk, which is celebrating its 50th anniversary this year, covers all major fields of science. We support entrepreneurs with our rich scientific experience, expertise, as well as the cutting edge technologies.The University of Gdańsk is a partner in numerous projects with the private sector. We are open to applying for joint R&D grants and projects, focused on solving specific challenges in companies.We carry out a wide range of diagnostic and research assignments in many fields of applied sciences such as biology, chemistry and biotechnology.The university also provides technologies and inventions that have a high potential for application. We are looking for business partners who are interested in the implementation of innovations.We encourage you to contact us for the details of potential cooperation.

44

We would like to invite you to participate in the special Technology Transfer Zone during the 7th Central European Congress of Life Sciences Eurobiotech. The Tech-nology Transfer Zone is integral part of the accompanying exhibition of biotechnology companies. Our aim is to present the scientific projects applied for commercialization and to demonstrate practical solutions and options for effective cooperation between science and business.

TECHNOLOGY TRANSFER ZONE

www.targi.krakow.pl www.expokrakow.com

congress budget and programme planningcomprehensive office management

coordination of the scientific programmenegotiations & supplier contracting

rental and arrangement of conference venueshotel reservations

transfers and information pointscatering services

running correspondence and financial settlements with congress participantsaccompanying exhibitions

preparing and printing promotional materialsaccompanying tourist and cultural programme

professional conference organizer operating in Krakow and throughout Poland20 years’ experience in the meetings industry

Targi w Krakowie Ltd.

Professional Congress Organizer

Targi w Krakowie Ltd. / EXPO Krakówul. Galicyjska 9, 31-586 Kraków tel. +48 12 651 90 49, kongresy@targi.krakow.pl

46

LIST OF EXHIBITORS

NAME OF THE COMPANY ..........................................................................STAND

A&A Biotechnology ...........................................................................................................3

APEXEL CO., LTD .......................................................................................................... 21

Bayer .............................................................................................................................. 11

BIOKOM ............................................................................................................................8

BIOMEDICA POLAND SP. Z O.O ................................................................................... 17

Bio Rad .............................................................................................................................7

Bio-Techne ........................................................................................................................2

Centre of Technology Transfer, Cracow University of Technology ................................ 18

Chałas & Partners .......................................................................................................... 20

Curiosis Inc. ................................................................................................................... 12

diCELLa.......................................................................................................................... 23

Elamed ........................................................................................................................... 15

Fundacja Małopolskie Centrum Transferu Technologii ................................................. 22

Genos s.c. .........................................................................................................................4

Hamilton Bonaduz AG ......................................................................................................1

IRtech ............................................................................................................................. 16

Lab-JOT ........................................................................................................................ 10

MGI Tech Co., Ltd. ............................................................................................................9

Sarstedt .......................................................................................................................... 19

Sartorius Poland Sp. z o.o. & Sartorius Stedim ............................................................ 13

STI Bartosz Czajkowski ....................................................................................................5

Sygnis Bio Technologies................................................................................................ 14

TK Biotech ...................................................................................................................... 24

UNIVERSITY OF GDAŃSK ...............................................................................................6

47

PRAGA

ROOM

48

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOTES